The Prognostic Value of Anion Gap in Predicting Major Adverse Cardiovascular Events Among Patients With ST-Segment Elevation Myocardial Infarction

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-70
SponsorUniversitas Diponegoro

About this trial

This study aims to evaluate the prognostic value of the anion gap in predicting major adverse cardiovascular events among patients with ST-segment elevation myocardial infarction. Researchers will collect information based on hospital registry as secondary data of in patient who had diagnosed as ST-segment elevation myocardial infarction and underwent primary percutaneous coronary intervention. The data consist of demographic data, clinical presentation, laboratory, and angiography result were collected from hospital registry by reviewing medical record. Then, the data was analyzed by using IBM SPSS Statistics v26.

Eligibility criteria

Qualifiers

Adults with 18 - 70 years old with diagnosis of STEMI who underwent PPCI

Disqualifiers

History of heart failure due to any causes

Cardiogenic shock before PPCI

Any infection at the time of presentation

Pregnant woman

Trial design

Treatments tested in this trial

  • Anion gap

Treatment groups

80 Participants
are divided into 1 treatment group

Sponsors and collaborators